Insulin Lispro Injection
Product Description
Fosun Wanbang (Jiangsu) Pharmaceutical Group Co.,Ltd.
-
Country/Region:China
-
On CPHI since:2015
-
Certificates:2
-
Employees:5000+
Company types
Primary activities
Categories
Specifications
Fosun Wanbang (Jiangsu) Pharmaceutical Group Co.,Ltd.
-
Country/Region:China
-
On CPHI since:2015
-
Certificates:2
-
Employees:5000+
Company types
Primary activities
More Products from Fosun Wanbang (Jiangsu) Pharmaceutical Group Co.,Ltd. (20)
-
Product Febuxostat
Commercial US DMF inprogress -
Product Glimepiride Tablets
China approved -
Product Guanfacine ER Tablets
USA Approved -
Product Heparin Sodium Injection
1ml:5000iu, USA approved -
Product Human Insulin
Commercial -
Product Insulin Glargine Injection
China approved -
Product Leflunomide Tablets
USA approved -
Product Liraglutide Injection
under clinical study -
Product Pitavastatin Calcium Tablets
China Approved -
Product Roxadustat Capsules
China under registration -
Product Semaglutide Injection
under clinical study -
Product Tofacitinib Tablets
China approved